Changes in Lymphocyte Subpopulations after Remdesivir Therapy for COVID-19: A Brief Report

Remdesivir (RDV) has demonstrated clinical benefit in hospitalized COronaVIrus Disease (COVID)-19 patients. The objective of this brief report was to assess a possible correlation between RDV therapy and the variation in lymphocyte subpopulations. We retrospectively studied 43 hospitalized COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Cianci, Rossella, Massaro, Maria Grazia, De Santis, Elisabetta, Totti, Beatrice, Gasbarrini, Antonio, Gambassi, Giovanni, Giambra, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573452/
https://www.ncbi.nlm.nih.gov/pubmed/37834421
http://dx.doi.org/10.3390/ijms241914973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573452/
https://www.ncbi.nlm.nih.gov/pubmed/37834421
http://dx.doi.org/10.3390/ijms241914973

Ejemplares similares